Filing Details
- Accession Number:
- 0001689813-19-000116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-11 21:43:18
- Reporting Period:
- 2019-12-09
- Accepted Time:
- 2019-12-11 21:43:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1689813 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1262325 | Eric Aguiar | C/O Aisling Capital Llc 888 Seventh Avenue, 12Th Floor New York NY 10106 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2019-12-09 | 4,072 | $20.79 | 4,072 | No | 4 | M | Indirect | By Spouse |
| Common Shares | Disposition | 2019-12-09 | 4,072 | $55.11 | 0 | No | 4 | S | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Employee Stock Option (Right to Buy) | Disposition | 2019-12-09 | 4,072 | $0.00 | 4,072 | $20.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,755 | 2027-12-06 | No | 4 | M | Indirect |
Footnotes
- These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 - $55.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- The option, representing a right to purchase a total of 30,436 shares was granted on December 7, 2017, vesting in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date. The optionholder previously exercised the option with respect to 7,609 shares on February 4, 2019.
- This employee stock option is held by the Reporting Person's spouse.
Billionaire Hedge Funds
